Toth Financial Advisory
MIRM icon

Toth Financial Advisory’s Mirum Pharmaceuticals MIRM Stock Holding History

Toth Financial Advisory’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$58.6K Sell
685
-9,600
-93% -$1M 0.01% 359
2026
Q2 		$1.2M Buy
+10,285
New +$1.03M 0.12% 133

Other funds holding MIRM

Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Secure Asset Management
Secure Asset Management Troy, Michigan $753M AUM 20.9% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Values First Advisors
Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Juncture Wealth Strategies
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
NorthCrest Asset Manangement
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
Contravisory Investment Management
Contravisory Investment Management Norwell, Massachusetts $552M AUM 32.44% 1-Year Est. Return

Toth Financial Advisory's MIRM Position: Q3 2026 in Review

Toth Financial Advisory reduced its Mirum Pharmaceuticals (MIRM) stake by 93% in Q3 2026, selling an estimated $1M and leaving 685 shares worth $58.6K. The position accounts for 0.01% of the portfolio, ranked #359.

Toth Financial Advisory first reported a position in MIRM in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.2M in Q2 2026. 37 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Toth Financial Advisory held 685 shares of Mirum Pharmaceuticals worth $58.6K as of Q3 2026.
  • Toth Financial Advisory sold 9,600 Mirum Pharmaceuticals shares in Q3 2026, an estimated $1M.
  • Mirum Pharmaceuticals made up 0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #359 holding.
  • Toth Financial Advisory first reported a position in Mirum Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • Toth Financial Advisory's Mirum Pharmaceuticals position peaked at $1.2M in Q2 2026.
  • 37 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.